Oral Abstracts from 3rd European Stroke Organisation Conference (ESOC 2017)

Useless, I don't see anything that addresses the neuronal cascade of death or any useful rehab strategies. Proves once again there is no strategy to get all stroke survivors 100% recovered.
http://journals.sagepub.com/doi/full/10.1177/2396987317705236

THE NORWEGIAN TENECTEPLASE STROKE TRIAL (NOR-TEST): RANDOMISED CONTROLLED TRIAL OF TENECTEPLASE VS. ALTEPLASE IN ACUTE ISCHAEMIC STROKE

 

EFFICACY OF EARLY COGNITIVE-LINGUISTIC TREATMENT FOR APHASIA DUE TO STROKE; A RANDOMISED CONTROLLED TRIAL (RATS-3)

 

CLOSURE OF PATENT FORAMEN OVALE, ORAL ANTICOAGULANTS OR ANTIPLATELET THERAPY TO PREVENT STROKE RECURRENCE (CLOSE): A RANDOMIZED CLINICAL TRIAL

 

PROBUCOL FOR PREVENTION OF CARDIOVASCULAR EVENTS IN ISCHEMIC STROKE PATIENTS WITH HIGH RISK OF CEREBRAL HEMORRHAGE (PICASSO) STUDY: A MULTICENTER, RANDOMIZED CONTROLLED TRIAL

 

PROGNOSTIC AND TREATMENT IMPACT OF PENUMBRAL IMAGING IN POOLED ANALYSIS OF RANDOMIZED TRIALS OF ENDOVASCULAR STENT THROMBECTOMY

 

TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET

 

OFF LABEL USE OF ALTEPLASE FOR ACUTE ISCHEMIC STROKE (AIS) IN PATIENTS OVER 80 YEARS OF AGE: INDIVIDUAL-PATIENT-DATA META-ANALYSIS OF EIGHT TRIALS

 

LOW-DOSE VERSUS STANDARD-DOSE ALTEPLASE BY AGE, ETHNICITY, AND SEVERITY OF ACUTE ISCHAEMIC STROKE: THE ENCHANTED TRIAL

 

THROMBOLYSIS IMPLEMENTATION IN STROKE (TIPS) TRIAL: A CLUSTER RANDOMISED CONTROL TRIAL OF IMPLEMENTATION STRATEGIES FOR INTRAVENOUS THROMBOLYSIS

 

CHARACTERISTICS, MANAGEMENT AND RESPONSE TO TREATMENT IN CHINESE VS. NON-CHINESE PARTICIPANTS IN THE ENCHANTED TRIAL

 

THE NORWEGIAN SONOTHROMBOLYSIS IN ACUTE STROKE STUDY (NOR-SASS). A RANDOMIZED CONTROLLED STUDY OF CONTRAST-ENHANCED SONOTHROMBOLYSIS

 

INTRAVENOUS THROMBOLYSIS IN PATIENTS WITH STROKE UNDER RIVAROXABAN USING DRUG SPECIFIC PLASMA LEVELS – EXPERIENCE WITH A STANDARD OPERATION PROCEDURE IN CLINICAL PRACTICE

 

PROFESSIONAL GUIDELINE VERSUS PRODUCT LICENCE SELECTION FOR TREATMENT WITH IV THROMBOLYSIS: COMPLIANCE WITH PRODUCT LICENCES IS HIGHEST IN LOWER EFFICIENCY SITES AND RESTRICTS THROMBOLYSIS USAGE

 

OUTCOME AFTER ISCHEMIC STROKE IN PATIENTS OVER 80 YEARS TREATED WITH IV THROMBOLYSIS IN THE 3–4.5H COMPARED TO 3H TIME WINDOW: RESULTS FROM SITS-ISTR

 

NON-VITAMIN-K-ANTAGONIST ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS STROKE OR TIA: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

 

EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS IN A POPULATION STUDY OF INCIDENT ATRIAL FIBRILLATION

 

PREDICTING RISK OF MAJOR BLEEDING IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION AFTER TIA OR STROKE: EXTERNAL VALIDATION OF RISK SCORES

 

EARLY RECURRENCE AND MAJOR BLEEDING IN PATIENTS WITH ACUTE ISCHAEMIC STROKE AND ATRIAL FIBRILLATION TREATED WITH DIRECT ORAL ANTICOAGULANTS. THE RAF-DOAC STUDY

 

EVALUATING THE EFFECTIVENESS AND SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED WITH VITAMIN-K ANTAGONISTS

 

POPULATION-BASED STUDY OF PROGNOSIS OF BRIEF EPISODES OF ATRIAL FIBRILLATION ON 5-DAY HOME CARDAIC RHYTHM MONITORING AFTER TIA AND ISCHAEMIC STROKE

 

PILOT STUDY OF CARDIAC MAGNETIC RESONANCE IMAGING IN EMBOLIC STROKE OF UNDETERMINED SOURCE (MR-ESUS)

 

COMPARATIVE EFFECTIVENESS OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AND WARFARIN IN THE SCOTTISH ATRIAL FIBRILLATION POPULATION: THE VALUE OF REAL WORLD EVIDENCE

 

PREDICTIVE FACTORS OF STROKE RECURRENCE IN PATIENTS WITH ISCHEMIC STROKE DUE TO ATRIAL FIBRILLATION

 

OPTIMAL TIMING TO START RIVAROXABAN ADMINISTRATION TO PREVENT RECURRENT EMBOLISM IN ACUTE STROKE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION (NVAF): THE RELAXED STUDY

 

NURSE-LED, TELEPHONE-BASED, SECONDARY PREVENTIVE FOLLOW-UP AFTER STROKE OR TIA IMPROVES BLOOD PRESSURE AND LDL CHOLESTEROL: THREE-YEAR RESULTS FROM THE RANDOMIZED CONTROLLED NAILED STROKE TRIAL

 

TICAGRELOR VERSUS ASPIRIN IN ACUTE EMBOLIC STROKE OF UNDETERMINED SOURCE (ESUS)

 

PRIMARY RESULTS OF EBBINGHAUS, A COGNITIVE STUDY OF PATIENTS ENROLLED IN THE FOURIER TRIAL

 

A CULTURALLY-TAILORED, SKILLS-BASED INTERVENTION TO REDUCE BLOOD PRESSURE IN A MULTI-ETHNIC GROUP OF MILD/MODERATE STROKE SURVIVORS WITH HYPERTENSION: RESULTS FROM THE DESERVE TRIAL

 

SECULAR TRENDS IN PROCEDURAL STROKE OR DEATH RISKS OF STENTING VERSUS ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS – A POOLED ANALYSIS OF RANDOMISED TRIALS

 

RESTENOSIS AFTER STENTING VERSUS ENDARTERECTOMY FOR SYMPTOMATIC CAROTID STENOSIS AND ITS RELATIONSHIP WITH RECURRENT STROKE IN THE RANDOMISED INTERNATIONAL CAROTID STENTING STUDY (ICSS)

 

ENDOVASCULAR TREATMENT VERSUS ENDARTERECTOMY FOR CAROTID ARTERY STENOSIS: RESULTS FROM THE UPDATED SYSTEMATIC COCHRANE REVIEW

 

THE EVOLUTION OF CAROTID INTERVENTION: SECULAR TRENDS IN STENT TYPE, CEREBRAL PROTECTION DEVICES AND MEDICATION IN ACST-2, A LARGE INTERNATIONAL RCT COMPARING SURGERY WITH STENTING

 

AN EPIGENOME WIDE ASSOCIATION STUDY REVEALS AN ALTERED METHYLATION PATTERN ASSOCIATED WITH ACUTE NEUROLOGICAL OUTCOME AFTER ISCHEMIC STROKE

RARE EXONIC VARIANTS IN EXTREMES OF MRI-MARKERS FOR CEREBRAL SMALL VESSEL DISEASE

TARGETED LIPID PROFILING DISCOVERS NOVEL PLASMA BIOMARKERS OF LARGE VESSEL STROKE: RESULTS OF THE ASPIRE-STROKE STUDY

DILATED PERIVASCULAR SPACES, A MARKER OF CEREBRAL SMALL VESSEL DISEASE, ARE HIGHLY HERITABLE

SERUM AMYLOID A AS AN EARLY PREDICTOR OF STROKE ASSOCIATED INFECTION

GENOME WIDE STUDY FOR RARE VARIANTS REVEALS LOCI ASSOCIATED WITH HEMORRHAGIC TRANSFORMATION AFTER RT-PA

PROTEOMIC SIGNATURE OF TIA/MILD STROKE FROM PERIPHERAL BLOOD SAMPLES DRAWN IN EMERGENCY DEPARTMENTS: THE SPECTRA STUDY

GENOME-WIDE INTERACTION ANALYSIS WITH HYPERTENSION IN ASSOCIATION WITH WHITE MATTER HYPERINTENSITY BURDEN: THE COHORTS FOR HEART AND AGING RESEARCH IN GENOMIC EPIDEMIOLOGY (CHARGE) CONSORTIUM

 

EXOME SEQUENCING AND CHIP ANALYSES OF SMALL SUBCORTICAL MRI-DEFINED BRAIN INFARCTS

IMPACT OF WHITE MATTER HYPERINTENSITIES, CEREBRAL MICROBLEEDS AND MEDIAL TEMPORAL LOBE ATROPHY ON SHORT AND LONG-TERM REHABILITATION OUTCOMES AFTER STROKE

STEPWISE RELATIONSHIP BETWEEN SEVERITY OF ACUTE CEREBROVASCULAR EVENTS AND PRE/POST-EVENT DEMENTIA: POPULATION-BASED STUDY OF TIA AND STROKE

PREDICTORS OF DEMENTIA AFTER TIA/STROKE: 15-YEAR POPULATION-BASED FOLLOW-UP STUDY

TOTAL SMALL VESSEL DISEASE SCORE AND RISK OF RECURRENT STROKE – VALIDATION IN TWO LARGE COHORTS

CEREBRAL MICROBLEEDS AND THE RISK OF INCIDENT ISCHEMIC STROKE IN CADASIL

UP-REGULATION OF COL4A1 AND COL4A2 GENES THROUGH VARIOUS MECHANISMS LEADS TO SEVERE EARLY ONSET ISCHAEMIC SMALL VESSEL DISEASE, INCLUDING PADMAL

SPATIAL RELATION BETWEEN LOBAR MICROBLEEDS AND JUXTACORTICAL PERIVASCULAR SPACES ON 7T MRI IN AMNESTIC MILD COGNITIVE IMPAIRMENT AND EARLY ALZHEIMER’S DISEASE

THE DIFFERENTIAL EVOLUTION OF ACUTE SMALL INFARCTS OVER TIME IN PATIENTS WITH SMALL VESSEL DISEASE

 

PRECISE HISTOLOGICAL-RADIOLOGICAL CORRELATIONS OF BRAIN PATHOLOGY IN SMALL VESSEL DISEASE

 

EFFECTS OF STATIN INTENSITY AND ADHERENCE ON THE LONG-TERM PROGNOSIS AFTER ACUTE ISCHEMIC STROKE: A NATIONWIDE POPULATION-BASED COHORT STUDY

THE PREDICTIVE VALUE OF PULSE PRESSURE DURING ACUTE STAGE OF ISCHEMIC STROKE FOR FUTURE MAJOR VASCULAR EVENTS

SOCIOECONOMIC STATUS AND THE RISK OF STROKE RECURRENCE. PERSISTING GAPS OBSERVED IN A NATIONWIDE SWEDISH STUDY 2001–2012

RISK OF DEATH, READMISSION, CARDIOVASCULAR AND BLEEDING EVENTS AMONG PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION AND MILD, MODERATE AND SEVERE ISCHEMIC STROKE

EMBOLIC STROKES OF UNDETERMINED SOURCE IN THE HELSINKI YOUNG STROKE REGISTRY: LONG-TERM OUTCOME

EARLY TIME COURSE OF MAJOR AND INTRACRANIAL BLEEDING IN PATIENTS WITH CEREBRAL ISCHAEMIA ON ANTIPLATELET THERAPY

POPULATION-BASED STUDY OF FREQUENCY, RISK FACTORS AND LONG-TERM PROGNOSIS OF TIA AND ISCHAEMIC STROKE IN PATIENTS WITH SYMPTOMATIC DISEASE IN OTHER VASCULAR BEDS

SELF-RATED HEALTH, ONE TO FIVE YEARS AFTER STROKE

PROGNOSTIC SIGNIFICANCE OF BLOOD PRESSURE VARIABILITY ON BEAT-TO-BEAT VERSUS AWAKE AMBULATORY AND DAY-TO-DAY MONITORING

INTRATHECAL BACLOFEN THERAPY COMPARED TO THE CONVENTIONAL TREATMENT: EFFICACY RESULTS IN THE MANAGEMENT OF POST-STROKE SPASTICITY OF THE SISTERS RANDOMIZED CONTROL TRIAL

MODAFINIL IN DEBILITATING FATIGUE AFTER STROKE (MIDAS): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER TRIAL

GENDER DIFFERENCE IN RESPONSE TO FAMILY-LED REHABILITATION AFTER STROKE

EARLY USE OF ABOBOTULINUMTOXINA IN ADULTS WITH POST-STOKE SPASTICITY IMPROVES MUSCLE TONE AND INCREASES TIME TO REINJECTION: RESULTS FROM ONTIME AND ABCDE S STUDIES

NOVEL NON-INVASIVE DYSPHAGIA DETECTION SYSTEM (DDS) FOR BEDSIDE ASSESSMENT OF SWALLOWING IN PATIENTS AT RISK OF OROPHARYNGEAL DYSPHAGIA: RESULTS FROM AN EXPLORATORY STUDY

 

ANALYSIS OF MORTALITY AND MORBIDITY AFTER PERCUTANEOUS ENDOSCOPIC GASTROSTOMY(PEG) AND RADIOLOGICALLY-INSERTED GASTROSTOMY(RIG) – AN EIGHT –YEAR FOLLOW UP STUDY FROM THE UK

OUTCOME MEASUREMENT IN STROKE UPPER LIMB REHABILITATION TRIALS: DO WE MEASURE WHAT MATTERS?

WHEN NEGLECT IS BEING NEGLECTED: THE POOR SENSITIVITY OF SYMPTOM-BASED ASSESSMENT OF INATTENTION IN ACUTE STROKE

POPULATION-BASED STUDY OF TEMPORAL TRENDS IN INCIDENCE, RISK FACTORS AND AETIOLOGY OF “YOUNG STROKE” IN OXFORDSHIRE, UK

ISCHEMIC STROKE ETIOLOGIC SUBTYPES DISTRIBUTION: A POPULATION-BASED STUDY AND A META-ANALYSIS

TRENDS IN STROKE SEVERITY AND BASELINE RISK PROFILE IN PATIENTS TREATED ON A COMPREHENSIVE STROKE UNIT IN NORWAY IN 1994 VERSUS 2012

DILATED PERIVASCULAR SPACES ARE ASSOCIATED WITH HIGH INCIDENT HEMORRHAGIC STROKE RISK

RAPID INCREASE OF THE INCIDENCE OF STROKE IN YOUNG ADULTS IN THE NETHERLANDS BETWEEN 1998 AND 2010

THE MEDIATING ROLE OF THE MICROVASCULATURE ON THE EFFECT OF SMOKING ON ISCHEMIC STROKE: A CAUSAL MEDIATION ANALYSIS

30-YEARS TREND IN BASELINE CARDIOVASCULAR RISK FACTORS AND OUTCOME FOLLOWING CAROTID ENDARTERECTOMY WITHIN THREE CONSECUTIVE RANDOMIZED TRIALS

EARLY LIFE RISK FACTORS FOR STROKE IN THE UK BIOBANK

PATENT FORAMEN OVALE IS NOT ASSOCIATED WITH NEW DIFFUSION WEIGHTED IMAGING LESIONS ONE WEEK AFTER AN ISCHEMIC STROKE

 

CLINICAL ANALYSIS COMPARING EFFICACY BETWEEN A DISTAL FILTER PROTECTION DEVICE AND PROXIMAL BALLOON OCCLUSION DEVICE DURING CAROTID ARTERY STENTING

OUTCOMES FROM MECHANICAL THROMBECTOMY IN THE UNITED KINGDOM: COMPARISON OF SAFE IMPLEMENTATION OF THROMBOLYSIS IN STROKE-THROMBECTOMY REGISTRY (SITS-TBY) WITH HERMES META-ANALYSIS ENDOVASCULAR TRIALS DATA

INTRACRANIAL ATHEROSCLEROTIC OCCLUSION ON ENDOVASCULAR REVASCULARIZATION THERAPY: ANALYSIS OF ACUTE STROKE DUE TO INTRACRANIAL ATHEROSCLEROTIC OCCLUSION AND NEUROINTERVENTION – KOREAN RETROSPECTIVE REGISTRY

NATIONAL RESULTS OF ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE 2011–2015, DENMARK

OUTCOME AND SAFETY OF ENDOVASCULAR TREATMENT IN DENMARK 2011–2015 APPLYING KEY INCLUSION CRITERIA FROM THE MR-CLEAN STUDY

 

RISK FACTORS FOR SYMPTOMATIC INTRACRANIAL HEMORRHAGE AFTER ENDOVASCULAR THERAPY IN ACUTE STROKE WITH LARGE VESSEL OCCLUSION IN THE ANTERIOR CIRCULATION

ACUTE ENDOVASCULAR TREATMENT OF CAROTID TANDEM LESIONS: STENTING OR NOT STENTING, THE NEVER ENDING STORY

OUT OF BOUNDS: ENDOVASCULAR TREATMENT OF STROKE BEYOND GUIDELINES IN A SINGLE CENTER EXPERIENCE

MECHANICAL THROMBECTOMY FOR STROKE IN THE ELDERLY

OUTCOME ANALYSIS FOR ANTIHYPERTENSIVE TREATMENT FOR ACUTE CEREBRAL HEMORRHAGE (ATACH) II TRIAL USING REPEATED SYSTOLIC BLOOD PRESSURE MEASURES

EFFICIENCY OF INTRAVENTRICULAR HEMORRHAGE REMOVAL IN THE CLOT LYSIS: EVALUATION OF ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE TRIAL (CLEAR III)

INTRAVENTRICULAR HEMORRHAGE: WHO DIES AND WHY: MORTALITY REVIEW FOR THE CLOT LYSIS: EVALUATION OF ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE TRIAL (CLEAR III)

PREDICTORS OF NEUROLOGICAL DETERIORATION IN INTRACEREBRAL HAEMORRHAGE: RESULTS OF INTERIM DATA FROM THE TICH-2 TRIAL

TARGETING EXPANSION IN INTRACEREBRAL HEMORRHAGE: INTENSIVE BLOOD PRESSURE REDUCTION AND NON-CONTRAST CT MARKERS

 

VERY EARLY HEMATOMA EXPANSION LIMITS EFFICACY OF HEMOSTATIC THERAPY IN THE SPOTLIGHT RANDOMIZED CONTROLLED TRIAL

WHITE MATTER LESIONS INFLUENCE ON INTRACEREBRAL HEMORRHAGE EXPANSION AND FUNCTIONAL OUTCOME: A SECONDARY ANALYSIS OF MISTIE-II AND CLEAR-III

INTENSIVE BLOOD PRESSURE LOWERING DOES NOT INCREASE RISK OF DIFFUSION WEIGHTED IMAGING HYPERINTENSE LESIONS IN INTRACEREBRAL HEMORRHAGE

AGGRESSIVE BLOOD PRESSURE REDUCTION IN ACUTE INTRACEREBRAL HEMORRHAGE INCREASES ACUTE CEREBRAL ISCHEMIA WITH CLINICAL DETERIORATION

NEUTROPHIL EXTRACELLULAR TRAPS IN THROMBI FROM PATIENTS WITH ACUTE ISCHEMIC STROKE

IMAGING-GUIDED ADVANCES IN A MOUSE MODEL OF RADIOLOGICALLY SILENT TRANSIENT ISCHAEMIC ATTACK: ULTRA-SENSITIVE MOLECULAR MRI AND CONTRAST-ENHANCED MRI DISCLOSE ENDOTHELIAL DYSFUNCTIONS AND ALTERED FLUID DRAINAGE

NOVEL THERANOSTIC PROTOCELLS FOR INTRACEREBRAL HEMORRHAGE

THROMBUS NEUTROPHIL EXTRACELLULAR TRAPS BURDEN IN THROMBI RETRIEVED DURING ENDOVASCULAR THERAPY ARE RESPONSIBLE FOR T-PA INDUCED THROMBOLYSIS RESISTANCE

NEURONAL PROTHROMBIN MEDIATES ASTROCYTE ACTIVATED EARLY PROTECTIVE RESPONSE VIA PROTEASE-ACTIVATED RECEPTORS (PAR-1) IN ISCHEMIA

MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS ARE ALTERED IN CERVICOCEREBRAL ARTERY DISSECTION – RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON INFLAMMATORY BIOMARKERS

REDUCED PLASMA LEVELS OF NEURAL CELL ADHESION MOLECULE ARE ASSOCIATED WITH EARLY SEIZURES IN STROKE PATIENTS

LYMPHOCYTES PREVENT HEMORRHAGIC TRANSFORMATION IN SEVERE ISCHEMIC STROKE

HEADS AND TAILS OF NATRIURETIC PEPTIDES: NEUROPROTECTIVE ROLE OF BRAIN NATRIURETIC

PARIETAL OPERCULUM AND MOTOR CORTEX ACTIVITIES PREDICT MOTOR RECOVERY IN MODERATE TO SEVERE STROKE (ON BEHALF OF ISIS-HERMES STUDY GROUP)METABOLOMIC PROFILING IN CADASIL

NON-TARGETED SERUM METABOLOMICS AFTER HUMAN ISCHEMIC STROKE IDENTIFIES ACUTELY ELEVATED 2-AMINOBUTYRIC ACID AND PREGNENOLONE SULFATE

 

INTERNAL CAROTID ARTERY DISSECTION IS ASSOCIATED WITH LONGER STYLOID PROCESS AND SHORTER STYLOID PROCESS – INTERNAL CAROTID ARTERY DISTANCE

PLAQUE INFLAMMATION IMAGING IS USEFUL IN PREDICTING RECURRENT CEREBRAL ISCHEMIA IN CAROTID STENOSIS

INCREASED PLATELET ACTIVATION IN MICRO-EMBOLI NEGATIVE RECENTLY SYMPTOMATIC VERSUS ASYMPTOMATIC CAROTID STENOSIS: RESULTS FROM THE HAEMOSTASIS IN CAROTID STENOSIS (HEIST) STUDY

JUXTALUMINAL ECHODENSITY AS AN INDEX OF CAROTID PLAQUE BEHAVIOUR

NEUROFILAMENT LIGHT CHAIN AS A SERUM MARKER FOR CEREBRAL SMALL VESSEL DISEASE

IMPAIRMENT OF CEREBROVASCULAR REACTIVITY IS ASSOCIATED WITH INCREASED WHITE MATTER HYPERINTENSITY AND PERIVASCULAR SPACE BURDENS IN PATIENTS WITH ISCHAEMIC STROKE PRESENTATIONS OF SMALL VESSEL DISEASE

 

DIAGNOSTIC CRITERIA FOR TRANSIENT ISCHAEMIC ATTACKS (TIA) VERSUS LONG-TERM PROGNOSIS: A POPULATION-BASED STUDY

 

LOWER DEMENTIA RISK WITH DIFFERENT CLASSES OF ANTIHYPERTENSIVE MEDICATION IN OLDER PATIENTS

AGE-SPECIFIC RISKS, SEVERITY, TIME-COURSE AND OUTCOME OF BLEEDING ON LONG-TERM ANTIPLATELET TREATMENT AFTER VASCULAR EVENTS: POPULATION-BASED STUDY

POPULATION-BASED STUDY OF PROGNOSTIC VALUE AND CONTROL OF NOCTURNAL BP AFTER TIA AND STROKE

THE DIAGNOSIS OF UNCERTAIN ORIGIN BENIGN TRANSIENT EVENTS (DOUBT) STUDY

THE ASSOCIATION OF ADULT VACCINATION AND THE RISK OF ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS

ANTIPLATELET REGIMEN FOR PATIENTS WITH BREAKTHROUGH STROKES WHILE ON ASPIRIN: A SYSTEMATIC REVIEW AND META-ANALYSIS

ARTERIAL STIFFNESS IS ASSOCIATED WITH BASAL GANGLIA ENLARGED PERIVASCULAR SPACES AND CEREBRAL SMALL VESSEL DISEASE LOAD

DRIP ‘N SHIP VERSUS DIRECT TO THROMBECTOMY CENTRE: CONDITIONAL PROBABILITY MODELLING IN IRELAND

MORTALITY AND DISABILITY ACCORDING TO BASELINE BLOOD PRESSURE IN ACUTE ISCHEMIC STROKE PATIENTS ELIGIBLE FOR THROMBECTOMY: A COLLABORATIVE POOLED ANALYSIS

ESO ESMINT EAN SAFE SURVEY ON ACUTE ENDOVASCULAR STROKE CARE IN EUROPE

ONE STOP MANAGEMENT OF ACUTE STROKE PATIENTS: MINIMIZING DOOR TO REPERFUSION TIMES

TIME TO TREATMENT AND FUNCTIONAL OTUCOME AFTER INTRA-ARTERIAL TREATMENT IN CLINICAL PRACTICE – RESULTS FROM THE MR CLEAN REGISTRY

TRANSFER-RELATED DELAY AND FUNCTIONAL OUTCOME AFTER INTRA-ARTERIAL TREATMENT; RESULTS FROM THE MR CLEAN REGISTRY

SAFETY AND FUNCTIONAL OUTCOME AFTER INTRA-ARTERIAL TREATMENT FOR ACUTE ISCHEMIC STROKE WITHOUT PRIOR INTRAVENOUS THROMBOLYSIS IN CLINICAL PRACTICE: RESULTS FROM THE MR CLEAN REGISTRY

THE IMPACT OF NATIONWIDE CENTRALLY ORGANIZED STROKE CARE SYSTEM ON RECANALIZATION RATES: CZECH REPUBLIC EXPERIENCE

VASCULAR AND CLINICAL OUTCOME IN ACUTE SYMPTOMATIC EXTRACRANIAL INTERNAL CAROTID ARTERY OCCLUSION

IMPACT OF CLINICAL TRIAL PARTICIPATION ON ‘DOOR-TO-NEEDLE’ TIME PERFORMANCE: THE ENCHANTED TRIAL

12 month outcomes from A Very Early Rehabilitation Trial (AVERT)

INTENSIVE VERSUS GUIDELINE ANTIPLATELET THERAPY IN PATIENTS WITH MINOR ISCHAEMIC STROKE: DATA FROM THE TRIPLE ANTIPLATELETS FOR REDUCING DEPENDENCY IN ISCHAEMIC STROKE (TARDIS) TRIAL

HYPOTHERMIA IN ADDITION TO DECOMPRESSIVE HEMICRANIECTOMY AFTER MALIGNANT INFARCTION

 

SPECIFIC POINT-OF-CARE TESTING OF COAGULATION IN PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS PART I (SPOCT-NOAC I)

 

ANTIBIOTIC PROPHYLAXIS IN ACUTE ISCHEMIC AND HEMORRHAGIC STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

 

DIAGNOSTIC VALUE OF NEW SEMIQUANTITATIVE IMAGING MARKERS OF CEREBRAL VENOUS THROMBOSIS: A MULTICENTER STUDY

 

TEMPORAL TRENDS IN STROKE MORTALITY RATES FROM 1987 TO 2012 ACCORDING TO SEX. THE DIJON STROKE REGISTRY

 

MARRIAGE, DIVORCE, SINGLE LIVING, WIDOWHOOD AND THE RISK FOR STROKE. A DANISH NATION-WIDE POPULATION-BASED STUDY

 

AGE- AND SEX-SPECIFIC ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE

 

TRAJECTORIES OF DEPRESSION SYMPTOMS LONG TERM AFTER STROKE IN MEN AND WOMEN: THE SOUTH LONDON STROKE REGISTER

 

TRENDS IN ISCHEMIC STROKE RATES BY SEX FROM 2000 TO 2013: RESULTS FROM THE BRAIN ATTACK SURVEILLANCE IN CORPUS CHRISTI PROJECT

 

SEX DIFFERENCES IN RESPONSE TO THROMBOLYSIS IN ACUTE ISCHEMIC STROKE: ENCHANTED RESULTS

 

POORER QUALITY OF LIFE AT 3–6 MONTHS AFTER STROKE IN WOMEN COMPARED TO MEN IS DUE TO AGE AND SEVERITY BUT NOT CLINICAL CARE

 

SEX DIFFERENCES IN STROKE OUTCOMES: ANALYSIS FROM THE SOUTH LONDON STROKE REGISTER

 

PUERPERIUM BUT NOT PREGNANCY IS A RISK FACTOR FOR CEREBRAL VENOUS THROMBOSIS

 

LOW FETAL HEMOGLOBIN PERCENTAGE IS ASSOCIATED WITH SILENT WHITE MATTER CHANGES IN ADULTS WITH HOMOZYGOUS SICKLE CELL DISEASE

 

SCREENING FOR MONOGENIC CEREBRAL SMALL VESSEL DISEASE USING WHOLE GENOME SEQUENCING

 

ADDITIONAL CORTICOSTEROID TREATMENT IMPROVES OUTCOME IN CHILDHOOD STROKE DUE TO TRANSIENT FOCAL ARTERIOPATHY

 

PREVALENCE AND TEMPORAL EVOLUTION OF COGNITIVE DYSFUNCTION IN YOUNG STROKE – FIRST DATA FROM A PROSPECTIVE SINGLE-CENTRE STUDY

 

FEASIBILITY AND SAFETY OF THROMBOLYSIS AND THROMBECTOMY IN CHILDREN WITH ACUTE ISCHAEMIC STROKE

 

SUBOPTIMAL USE OF SECONDARY PREVENTION AFTER STROKE IN YOUNG ADULTS: THE FUTURE STUDY

 

RARE RNF213 VARIANTS LOCATED IN THE C-TERM REGION ENCOMPASSING THE RING DOMAIN ARE ASSOCIATED WITH MOYAMOYA IN CAUCASIANS

 

AFTER 30-YEARS INCREASING INCIDENCE OF HOSPITALIZATION FOR STROKE IN YOUNG ADULTS INCIDENCE IS NOW DECREASING. A NATION-WIDE POPULATION-BASED STUDY OF STROKE IN DANISH HOSPITALS 1980–2014

 

UTILITY OF CURRENT THROMBOPHILIA SCREENING IN YOUNG STROKE AND TIA PATIENTS

 

SEROTONIN REUPTAKE INHIBITORS AND RISK OF SYMPTOMATIC INTRACEREBRAL HEMORRHAGE FOLLOWING THROMBOLYSIS – FINDINGS FROM THE TRISP COLLABORATION

 

INTRAVENOUS THROMBOLYSIS FOR PATIENTS WITH IN-HOSPITAL STROKE ONSET: PROPENSITY-MATCHED ANALYSIS FROM THE SITS-EAST REGISTRY

 

REDUCING DOOR-TO-NEEDLE TIMES AT 17 HOSPITALS TO 36 MINUTES

 

EXPLANATIONS OF LATE ADMISSION OUTSIDE THE THERAPEUTIC TIME WINDOW IN ACUTE ISCHEMIC STROKE: INTERVIEW OF 1114 STROKE PATIENTS

 

FIVE-YEAR SURVIVAL AFTER THROMBOLYSIS: A PROPENSITY SCORE MATCHED STUDY USING THE SOUTH LONDON STROKE REGISTER

 

LOW THROMBIN GENERATION PREDICTS POOR PROGNOSIS IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS

 

IMPACT OF STROKE CODE: AN ATTEMPT TO IMPROVE INTRAVENOUS THROMBOLYSIS RATE & SHORTEN DOOR TO NEEDLE TIME IN ACUTE ISCHEMIC STROKE

 

INFLUENCE OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS ON TPA-USE OVER TIME: A MULTIVARIATE ANALYSIS OF PATIENT-DATA IN THE AUSTRIAN STROKE-UNIT REGISTRY

 

THE ROLE OF PRO- AND ANTI-INFLAMMATORY CYTOKINES IN ISCHEMIC STROKE PATIENTS TREATED WITH TPA THROMBOLYSIS: RESULTS FROM THE MAGIC STUDY

 

ATRIAL FIBRILLATION IN TIA AND ISCHEMIC STROKE PATIENTS WITH A PRIOR STROKE IN COMPARISON TO THOSE WITHOUT. A SWEDISH STROKE REGISTER (RIKSSTROKE) STUDY

 

WHITE MATTER HYPERINTENSITY MORPHOMETRY PROVIDES NOVEL INFORMATION ABOUT FUTURE RISK OF STROKE

 

GAMMA-GLUTAMYL TRANSFERASE PREDICTS STROKE RISK INDEPENDENT OF ALCOHOL CONSUMPTION: A KOREAN NATIONAL SAMPLE COHORT STUDY

 

EMBOLIC STROKES OF UNDETERMINED SOURCE IN THE HELSINKI YOUNG STROKE REGISTRY: BASELINE CHARACTERISTICS

 

AMBULATORY BLOOD PRESSURE LEVELS RELATE TO WHITE MATTER HYPERINTENSITIES PROGRESSION IN PRIMARY HIPERTENSIVES. RESULTS FROM THE ISSYS (INVESTIGATING SILENT STROKES IN HYPERTENSIVES: A MRI STUDY)

 

CEREBRAL ARTERIAL PULSATILITY IS ASSOCIATED WITH LEUKOARAIOSIS AND RECURRENT CEREBROVASCULAR EVENTS INDEPENDENTLY OF AGE AND BLOOD PRESSURE

 

BASELINE COGNITIVE SCORE AT TIME OF FIRST TIA/STROKE PREDICTS RISK AND SEVERITY OF RECURRENT STROKE: POPULATION-BASED STUDY

 

7 YEAR TRENDS IN SUBDURAL HAEMORRHAGE: INCIDENCE AND ASSOCIATION WITH ANTICOAGULATION USAGE

 

RUPTURE RISK FOR FAMILIAL COMPARED TO SPORADIC INTRACRANIAL ANEURYSMS

 

IMPACT OF TRANSCRANIAL DOPPLER ULTRASOUND ON LOGISTICS AND OUTCOMES IN PATIENTS TREATED WITH INTRAVENOUS THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE. RESULTS FROM THE SITS-ISTR

 

PREHOSPITAL STROKE SCALE (FAST PLUS TEST) PREDICTS PATIENTS WITH LARGE ARTERIAL VESSEL INTRACRANIAL OCCLUSION

 

WHICH HOSPITAL-LEVEL ORGANISATIONAL FACTORS CONTRIBUTE TO THE VARIATION IN MORTALITY FOR STROKE PATIENTS?

 

BETWEEN AND WITHIN CENTER EFFECTS OF VOLUME ON WORKFLOW AND OUTCOME IN INTRA-ARTERIAL TREATMENT FOR ACUTE ISCHEMIC STROKE: RESULTS FROM THE MR CLEAN REGISTRY

 

VARIATION IN THE USE OF URINARY CATHETERS IN ACUTE STROKE: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL DATA

 

COST-EFFECTIVENESS OF ENDOVASCULAR THERAPY USING MECHANICAL THROMBECTOMY DEVICES FOR ACUTE ISCHAEMIC STROKE

 

VARIATION IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM (DVT AND PE) ACROSS THE WORLD: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL DATA

 

VARIATION IN THE IDENTIFICATION AND MANAGEMENT OF DYSPHAGIA AND PNEUMONIA ACROSS THE WORLD: EXPLORATION OF HEAD POSITION IN STROKE TRIAL (HEADPOST) TRIAL DATA

 

HOW USEFUL IS SIMULATION TRAINING

 

MECHANICAL THROMBECTOMY FOR MINOR AND MILD STROKE PATIENTS HARBORING LARGE VESSEL OCCLUSION IN THE ANTERIOR CIRCULATION: A MULTICENTER CASE CONTROL STUDY

 

A NON-INFERIORITY, RANDOMIZED TRIAL OF THE SAFETY AND EFFECTIVENESS OF THE PENUMBRA 3D REVASCULARIZATION DEVICE AS AN ADJUNCT TO ASPIRATION IN ACUTE ISCHEMIC STROKE

 

ECONOMIC EVALUATION ALONGSIDE THE MULTICENTER RANDOMIZED CLINICAL TRIAL OF ENDOVASCULAR TREATMENT FOR ACUTE ISCHEMIC STROKE IN THE NETHERLANDS – MR CLEAN TRIAL

 

STRATIS REGISTRY: USE OF GENERAL ANESTHESIA AND IMPACT ON CLINICAL OUTCOME

 

MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE ON ANTICOAGULATION THERAPY

 

SAFETY AND OUTCOME OF INTRA-ARTERIAL TREATMENT FOR MINOR ISCHEMIC STROKE: RESULTS OF MR CLEAN REGISTRY

 

ASSOCIATION OF COLLATERAL STATUS ON BASELINE CTA WITH CLINICAL OUTCOME IN ACUTE ISCHEMIC STROKE; RESULTS FROM THE MR CLEAN REGISTRY

 

COMPARISON OF RADIOLOGICAL OUTCOMES IN PATIENTS WITH ACUTE ISCHEMIC STROKE TREATED WITH DIFFERENT THROMBECTOMY TECHNIQUES

 

CLINICAL OUTCOME OF ACUTE ISCHEMIC STROKE PATIENTS WITH EMERGENT ARTERIAL TANDEM OCCLUSIONS BY CERVICAL CAROTID TYPE OF REVASCULARIZATION

 

PREDICTORS FOR GOOD COLLATERALS IN 857 PATIENTS WITH ACUTE ISCHEMIC STROKE AND PROXIMAL MIDDLE CEREBRAL ARTERY OCCLUSION

 

THE CORE OF INFARCTION IN CT PERFUSION: RELIABLE ESTIMATOR OF REAL INFARCTION?

 

VALIDATING A PREDICTIVE MODEL OF ACUTE ADVANCED IMAGING BIOMARKERS IN ISCHEMIC STROKE

 

EXTENDING THE TIME FOR THOMBOLYSIS IN EMERGENCY NEUROLOGICAL DEFICITS (EXTEND) – PENUMBRAL CHARACTERISTICS AMONG PATIENTS 4.5-9 HRS AND WAKE – UP STROKE

 

REVISING COLLATERAL SCORING ON SINGLE-PHASE CTA: INSIGHTS GAIN FROM MULTI-PHASE CTA

 

QUANTITATIVE ASSESSMENT OF PLAQUE ENHANCEMENT IN SYMPTOMATIC INTRACRANIAL ATHEROSCLEROTIC LESIONS: A HIGH RESOLUTION MAGNETIC RESONANCE IMAGING STUDY

 

CLINICAL CORRELATES, PROGNOSTIC IMPLICATIONS AND ETHNIC DIFFERENCES OF PERIVASCULAR SPACES IN PATIENTS WITH TIA AND ISCHAEMIC STROKE

 

A CLINICAL PREDICTION RULE WOULD ALLOW MORE EFFECTIVE CTA UTILIZATION OF VASCULAR IMAGING FOR SUSPECTED MILD ACUTE CEREBROVASCULAR (ACVS) IN THE EMERGENCY DEPARTMENT

 

IS INFARCT VOLUME ON CT A USEFUL PROXY FOR FUNCTIONAL OUTCOME? RESULTS FROM THE MR CLEAN TRIAL

 

CORTICAL SUPERFICIAL SIDEROSIS IN DIFFERENT TYPES OF CEREBRAL SMALL VESSEL DISEASE

 

ACUTE ISCHEMIC LESIONS ARE ASSOCIATED WITH CORTICAL SUPERFICIAL SIDEROSIS IN SPONTANEOUS INTRACEREBRAL HEMORRHAGE

 

LACK OF EARLY IMPROVEMENT PREDICTS POOR CLINICAL OUTCOME FOLLOWING ACUTE INTRACEREBRAL HEMORRHAGE

 

ASSOCIATIONS WITH HAEMORRHAGIC TRANSFORMATION IN ACUTE ISCHEMIC STROKE

 

PREDICTING PRESENCE OF MACROVASCULAR CAUSES IN PATIENTS WITH NON-TRAUMATIC INTRACEREBRAL HAEMORRHAGE BASED ON PATIENT AND HAEMORRHAGE CHARACTERISTICS; THE DIAGRAM PREDICTION SCORE

 

SMASH-U VERSUS H-ATOMIC: A RANDOMIZED HEAD-TO-HEAD COMPARISON FOR THE ETIOLOGIC CLASSIFICATION OF PATIENTS WITH INTRACEREBRAL HEMORRHAGE

 

IMPLEMENTATION OF AN ACUTE CARE BUNDLE FOR INTRACEREBRAL HAEMORRHAGE: EXPERIENCE AT A UK COMPREHENSIVE STROKE CENTRE AND ASSOCIATED REDUCTION IN 30-DAY CASE FATALITY

 

BETTER FUNCTIONAL OUTCOME AND LOWER RISK OF MORTALITY FOR PATIENTS WITH INTRACRANIAL HEMORRHAGE ON STROKE UNITS COMPARED TO INTENSIVE CARE UNITS AND NORMAL WARDS

 

ABSOLUTE RISK AND PREDICTORS OF THE GROWTH OF ACUTE SPONTANEOUS PRIMARY INTRACEREBRAL HAEMORRHAGE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

 

LONG-TERM PREDICTORS OF MORTALITY AND FUNCTIONAL OUTCOME AFTER DECOMPRESSIVE HEMICRANIECTOMY FOR MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION

 

TIME-COURSE OF EVOLUTION OF FUNCTIONAL RECOVERY AND CAUSE-SPECIFIC MORTALITY AFTER ISCHAEMIC STROKE: IMPLICATIONS FOR TRIAL DESIGN AND INTERPRETATION

 

DERIVATION AND VALIDATION OF A NOVEL, PARSIMONIOUS, BIOMARKER-BASED PROGNOSTIC SCORE IN ISCHEMIC STROKE: THE CORISK-SCORE

 

PERFORMANCE OF THE ORDINAL VERSUS DICHOTOMIZED MODIFIED RANKIN SCALE IN PREDICTING 5-YEAR DEATH, DISABILITY, AND HEALTHCARE COSTS AFTER ISCHAEMIC STROKE: IMPLICATIONS FOR CLINICAL TRIALS

 

IMPACT OF ANTI-N-METHYL-D-ASPARTATE-RECEPTOR (NMDAR) NR1 ANTIBODIES ON LONG-TERM FUNCTIONAL OUTCOME IN STROKE PATIENTS

 

IMPACT OF STROKE ASSOCIATED PNEUMONIA ON MORTALITY, LENGTH OF HOSPITAL STAY AND FUNCTIONAL OUTCOME FOLLOWING ACUTE STROKE

 

OUTCOME AFTER POSTERIOR CIRCULATION STROKE – PROPENSITY SCORE MATCHING ANALYSIS FROM THE AUSTRIAN STROKE UNIT REGISTRY

 

COMPARISON OF LONG-TERM SPONTANEOUS FUNCTIONAL RECOVERY AND RESPONSE TO TREATMENT WITH MLC601 BETWEEN CORTICAL AND NON-CORTICAL STROKES – THE CHIMES-E STUDY

 

REDUCTION IN MORTALITY AFTER STROKE IN YOUNG ADULTS IN THE NETHERLANDS